A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants
Clinical trial NCT05278663 · COMPLETED
Trial details
- NCT number
- NCT05278663
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-14
- Primary completion
- 2023-09-04
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.